In Sweden, the research & development by business enterprise, pharmaceutical industry in constant ppp $ currently stands at 976.01 million, reflecting an increase of 131.84 million (15.6%) compared to 2020.
Research & development by business enterprise, pharmaceutical industry in constant PPP $ in Sweden
No matching regions
Similar regions to Sweden
Business R&D pharmaceutical in constant PPP $
More indicators for Sweden
Government R&D in security as % of government support
2.1%
-0.33%
(2021)
Higher-education-finacing R&D financed by general university in local currency
181,501.95M
+16,181.95M
(2021)
R&D financed by rest of the world in local currency
218,622.84M
+67,392.84M
(2021)
Government R&D financed by rest of the world in local currency
1,858.26M
-1,101.74M
(2021)
Business R&D financed by rest of the world in local currency
185,804.74M
+67,514.74M
(2021)
Non-profit R&D growth rate
-0.36%
-1.64%
(2022)
Sweden Business R&D pharmaceutical in constant PPP $ between 2007 and 2021
| Period | Business R&D pharmaceutical in constant PPP $ | Change |
|---|---|---|
| 2021 | 976.01M | +131.84M |
| 2020 | 844.17M | +119.89M |
| 2019 | 724.28M | -27.98M |
| 2018 | 752.26M | -68.70M |
| 2017 | 820.96M | +8.35M |
| 2016 | 812.60M | -43.89M |
| 2015 | 856.50M | +89.11M |
| 2014 | 767.38M | -49.46M |
| 2013 | 816.85M | -33.30M |
| 2012 | 850.15M | -77.15M |
| 2011 | 927.30M | +112.54M |
| 2010 | 814.76M | +43.41M |
| 2009 | 771.35M | -252.09M |
| 2008 | 1,023.44M | -75.16M |
| 2007 | 1,098.61M |